Oxford BioMedica PLC OXBDF:OTCPK

RT Quote | Exchange | USD
Last | 05/17/22 EDT
6.36UNCH (UNCH)
52 week range
5.60 - 22.86
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.36
  • 52 Week High22.86
  • 52 Week High Date09/23/21
  • 52 Week Low5.60
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap526.1M
  • Shares Out86.18M
  • 10 Day Average Volume3,149.25
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-61.88

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.36
  • 52 Week High22.86
  • 52 Week High Date09/23/21
  • 52 Week Low5.60
  • 52 Week Low Date05/12/22
  • Market Cap526.1M
  • Shares Out86.18M
  • 10 Day Average Volume3,149.25
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-61.88

RATIOS/PROFITABILITY

  • EPS (TTM)0.31
  • P/E (TTM)20.41
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Oxford BioMedica PLC

There is no recent news for this security.

Profile

MORE
Oxford BioMedica Plc is a United Kingdom-based gene and cell therapy company. The Company and its subsidiaries have developed lentiviral vector delivery system, LentiVector platform, which the Company leverages to develop in vivo and ex vivo products both in-house and with partners. Its LentiVector delivery platform has created a portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology, central nervous system (CNS) disorders and liver...
Stuart Henderson
Deputy Chair and Senior Independent Non-Executive Director
Roch Doliveux
Non-Executive Chairman of the Board
Nick Page
Chief Operating Officer
Stuart Paynter
Chief Financial Officer, Executive Director
James Miskin
Chief Technical Officer
Natalie Walter
General Counsel
Address
Windrush Court, Transport Way
Oxford
OX4 6LT
United Kingdom